Skip to content

Category: Biotechnology

Cambridge Isotope Laboratories Launches ISOLED-D: Revolutionary Deuterated Reagents for OLED Manufacturing

By API User

New ISOLED-D™ line delivers premium, scalable deuterated reagents for OLED synthesis, supporting the industry from R&D through commercial production with CIL’s global manufacturing and expertise. TEWKSBURY, MASSACHUSETTS / ACCESS Newswire / May 20, 2025 / Cambridge Isotope Laboratories, Inc. (CIL), the global leader in stable isotope-labeled products, announces the launch of ISOLED-D™, a groundbreaking line … Continued

LTR Pharma Limited (ASX:LTP) Expands National Patient Access for Erectile Dysfunction Treatment via Pharmacy Network Rollout

By API User

Dysfunction Treatment via Pharmacy Network Rollout 20 May 2025 – Sydney, Australia | LTR Pharma has announced the expansion of patient access to its fast-acting erectile dysfunction (ED) treatment, SPONTAN®, via a nationwide rollout through pharmacies dispensing under the TGA’s Special Access Scheme (SAS) and Authorised Prescriber Scheme (APS). SPONTAN® will now be available at … Continued

Optiscan Imaging (ASX:OIL) Progresses Robotic Surgery Collaboration with Mayo Clinic

By API User

Optiscan and Mayo Clinic have combined to significantly advance the development of a digital confocal laser endomicroscopic imaging system for use in robotic surgery.  Highlights Optiscan, in combination with the Mayo Clinic, has advanced the development of its digital confocal laser endomicroscopic imaging system for use in robotic surgery. This development project has evolved out … Continued

CLEO Advances Commercial Product Development with Completion of Alpha Testing

By API User

Highlights Completion of alpha testing using commercial prototypes of CLEO’s Ovarian Cancer pre-surgical triage assay kits Testing was conducted at CLEO’s laboratory and confirmed:– Robust and reproducible performance of all assay kit components;– Ability to differentiate Ovarian Cancer from benign disease;– Performance consistent with CLEO’s previously published in-house testing. CLEO now moves to next phase of … Continued

LTR Pharma (ASX:LTP) Signs Collaborative Agreement to Develop New Novel Intranasal Treatment for Oesophageal Motility Disorders

By API User

8 May 2025 – Sydney, Australia | LTR Pharma Limited (ASX:LTP) has entered into a development agreement with US-based Strategic Drug Solutions, Inc. (SDS) to co-develop OROFLOW®, a novel intranasal spray designed to treat Oesophageal Motility Disorders (OMD). These are a group of conditions that impair the ability to swallow and significantly impact quality of … Continued

Comparative Analysis Reports Superiority of OncoSil(TM) Over Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer

By API User

Sydney, Australia – 7 May 2025: Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) (“OncoSil” or “the Company”) is pleased to announce the results of the first comparative analysis of outcomes in patients with unresectable or borderline-resectable locally advanced pancreatic cancer (LAPC) receiving either OncoSil™ or Stereotactic Body Radiation Therapy (SBRT) in addition to … Continued

Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards

By API User

With six newly established, identical BSL-2 laboratories now operational, biologics CDMO Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks VILNIUS, LT / ACCESS Newswire / May 5, 2025 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based … Continued

BlinkLab Limited (ASX:BB1) Raises $7.66M to Advance AI-Powered Diagnostics for Autism and ADHD Trials

By API User

Highlights: A$7.66 million capital raise completed via a strongly supported placement to domestic and international sophisticated and institutional investors. Issue price of A$0.30 per share, representing a 16.7% discount to the last traded price and a 15.8% discount to the 15-day VWAP. The Board and Management are committed to contribute A$210,000 (subject to shareholder approval). … Continued

OncoSil Medical (ASX:OSL) Tender Process for CRO to Undertake G-BA Study Commences

By API User

Sydney, Australia – 30 April 2025: Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) (“OncoSil” or “the Company”) is pleased to announce that the Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) in Germany has officially initiated a European-wide tender process to identify and appoint a Contract Research Organisation (CRO). The selected CRO will be responsible … Continued

Optiscan Imaging (ASX:OIL) Quarterly Activities and Cash Flow Report

By API User

Highlights for the Quarter • Optiscan revealed InForm™, its next generation microscopic medical imaging device specifically designed for pathology workflows. • Optiscan received $1.775m R&D tax refund, $1.0m more than in previous years, due to the successful Advance and Overseas Finding application. • A comprehensive review of operations, sales and marketing functions, and clinical and regulatory strategy occurred, … Continued